. 2010 Nov 30;117(4):1408–1414. doi: 10.1182/blood-2010-07-299099

Table 1.

Effects of sBD1 on thrombus size and TF expression in murine macrophages induced by IgG-APS

Treatments	Thrombus size, μm²	TF expression in macrophages, AU
IgG-APS	4094.4 ± 1036.8^*	10.1 ± 1.4^†
IgG-NHS	287.4 ± 110.0	3.2 ± 0.5
IgG-APS + sBD1	665.0 ± 173.0	4.4 ± 0.6
IgG-NHS + sBD1	486.0 ± 164.0	3.2 ± 0.7
Dimer	3757 ± 162^‡	13.4 ± 3.7^§
Monomer	552.0 ± 79.6	3.4 ± 0.8
Dimer + sBD1	533 ± 148	6.9 ± 1.5
Monomer + sBD1	552.0 ± 133.0	4.9 ± 1.2

AU indicates arbitrary unit; IgG-APS, immunoglobulin G from a patient with antiphospholipid syndrome; IgG-NHS, immunoglobulin G from a patient with normal human serum; sBD1, soluble binding domain 1 of ApoER2; and TF, tissue factor.

Statistically significant from their controls and from sBD1-treated mice; IgG-APS (*P < .0001) and †(P < .0001) or dimer (‡P = .0044) and (§P = .0001).